Could getting rid of old cells turn back the clock on aging?

James Kirkland started his career in 1982 as a geriatrician, treating aging patients. But he found himself dissatisfied with what he could offer them. “I got tired of prescribing wheelchairs, walkers and incontinence devices,” recalls Kirkland, now at the Mayo Clinic in Rochester, Minnesota. He knew that aging is considered the biggest risk factor for … Read more

New study involving Alabama patients sorts long COVID into four types

Researchers relying partly on reports of Alabamians experiencing long COVID have created four new subcategories of the disease to help doctors route patients toward the best treatments. The study was published last month in Nature Medicine. Researchers relied on data from Alabama, Florida, Georgia and New York. According to the Centers for Disease Control, Alabama … Read more

Injectable Drugs Market to Surpass US$ 782.7 Mn, Growing at a Healthy CAGR of 7.9% between 2023 and 2030 | Baxter International Inc., Gilead Sciences Inc., GlaxoSmithKline

The growing frequency of chronic disorders like cancer and growth in the biologics market or rise in demand for biologics globally, causing the world injectable drugs market’s robust growth. Furthermore, growth in acceptance of injectable drugs worldwide is estimated to drive the growth of the market. However, the growth of the world injectable drugs market … Read more

Study finds how obesity triggers diabetes, may help prevent, delay disease

A new study has uncovered details about the mechanism of how obesity triggers diabetes, which could provide researchers with a target to help prevent or delay diabetes in some of those at risk. People who are overweight or obese have a significantly increased risk of developing diabetes, but exactly how that happens is not … Read more

Mid-Size Pharmaceutical Market to Exhibit Increased Demand in the forecast Period 2022 to 2028

The Insight Partners 2023 Mid-Size Pharmaceutical Market is expected to reach US$ 1,000,584.3 Million by 2028 NEW YORK, UNITED STATES, January 12, 2023 / — According to The Insight Partners new research study on “Mid-Size Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Drug Development Type, Formulation, and Therapy … Read more

Pesticides Not Only Linked to Parkinson’s Disease Development, But Accelerating Disease Symptoms

(Beyond Pesticides, January 12, 2023) Exposure to certain pesticides among individuals diagnosed with Parkinson’s disease (PD) can increase the risk of symptom progression. According to a study published in Science of the Total Environment, nearly 20 percent of pesticides associated with the onset of PD also increase the risk of faster decline in motor and non-motor function. … Read more

Alaska’s flu season appears to have peaked. Anchorage’s ‘snowmageddon’ may have helped.

Alaska’s flu cases and hospitalization rates are declining after hitting the state hard this winter, according to a weekly report put out by the Alaska Department of Health. That report shows a downward curve in cases beginning in mid-December, a potential reprieve from a cold and flu season that began earlier than usual, putting intense … Read more

Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study

Abstract Objectives To determine the clinical sequelae of long covid for a year after infection in patients with mild disease and to evaluate its association with age, sex, SARS-CoV-2 variants, and vaccination status. Design Retrospective nationwide cohort study. Setting Electronic medical records from an Israeli nationwide healthcare organisation. Population 1 913 234 Maccabi Healthcare Services members of … Read more

Inflammation Biomarker Potential Investigated in New CRSwNP Study

The utility of pro-inflammatory mediator S100A4 to act as a biomarker in chronic rhinosinusitis with nasal polyps (CRSwNP), and to be used as a classification value in endotyping for CRSwNP, has been demonstrated in a new study published in Frontiers in Surgery. Already known to have potential links with airway inflammatory diseases, the authors of … Read more

Patients With Inflammatory Disorders May Benefit From Psilocybin Treatment

Psilocybin is derived from certain types of mushrooms and has been proven to affect serotonin receptors. Data from a clinical study evaluating psilocybin as a therapeutic for inflammatory disorders in 3 different patient populations, such as patients with Parkinson disease, bipolar disorder, and chronic pain, are expected to be released by the end of April … Read more